The analysis of transcriptomics profiles of PBMC from PDA patients after CT showed that “CT exhausted/regulatory” patients display a higher expression of IL1R antagonist related genes (IL1R2, IL1RN). This evidence concerns the gene IL1R2 and Patent ductus arteriosus.